Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Cell Reports
|
July 26, 2016
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
Alison M Kurimchak, Claude Shelton, Kelly E Duncan, et al.
Blood
|
January 7, 2009
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics
Jayme D Allen, Zahara M Jaffer, Su-Jung Park, et al.
Human Molecular Genetics
|
June 2, 2021
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)
Eric Hawley, Jeffrey Gehlhausen, Sofiia Karchugina, et al.
Science Signaling
|
February 20, 2020
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma
Alison M Kurimchak, Carlos Herrera-Montávez, Jennifer Brown, et al.
Circulation Research
|
January 9, 2019
Pak2 as a Novel Therapeutic Target for Cardioprotective Endoplasmic Reticulum Stress Response
Pablo Binder, Shunyao Wang, Maria Radu, et al.
Iscience
|
March 14, 2022
Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy
Namrita Kaur, Andrea Ruiz-Velasco, Rida Raja, et al.
American Journal of Medical Genetics. Part A
|
January 29, 2011
Back to the future: proceedings from the 2010 NF Conference
Susan M Huson, Maria T Acosta, Allan J Belzberg, et al.
Frontiers in Cell and Developmental Biology
|
February 3, 2022
p21-Activated Kinase 1 Promotes Breast Tumorigenesis <i>via</i> Phosphorylation and Activation of the Calcium/Calmodulin-Dependent Protein Kinase II
Héctor I Saldivar-Cerón, Olga Villamar-Cruz, Claire M Wells, et al.
Breast Cancer Research : BCR
|
April 24, 2015
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents
Christy C Ong, Sarah Gierke, Cameron Pitt, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Cell Reports
|
July 26, 2016
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
Alison M Kurimchak, Claude Shelton, Kelly E Duncan, et al.
Blood
|
January 7, 2009
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics
Jayme D Allen, Zahara M Jaffer, Su-Jung Park, et al.
Human Molecular Genetics
|
June 2, 2021
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)
Eric Hawley, Jeffrey Gehlhausen, Sofiia Karchugina, et al.
Science Signaling
|
February 20, 2020
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma
Alison M Kurimchak, Carlos Herrera-Montávez, Jennifer Brown, et al.
Circulation Research
|
January 9, 2019
Pak2 as a Novel Therapeutic Target for Cardioprotective Endoplasmic Reticulum Stress Response
Pablo Binder, Shunyao Wang, Maria Radu, et al.
Iscience
|
March 14, 2022
Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy
Namrita Kaur, Andrea Ruiz-Velasco, Rida Raja, et al.
American Journal of Medical Genetics. Part A
|
January 29, 2011
Back to the future: proceedings from the 2010 NF Conference
Susan M Huson, Maria T Acosta, Allan J Belzberg, et al.
Frontiers in Cell and Developmental Biology
|
February 3, 2022
p21-Activated Kinase 1 Promotes Breast Tumorigenesis <i>via</i> Phosphorylation and Activation of the Calcium/Calmodulin-Dependent Protein Kinase II
Héctor I Saldivar-Cerón, Olga Villamar-Cruz, Claire M Wells, et al.
Breast Cancer Research : BCR
|
April 24, 2015
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents
Christy C Ong, Sarah Gierke, Cameron Pitt, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Page
of 18